The report shows that HBM chip market is set to grow at an annual rate of 42% between now and 2033, due to its importance to AI computing SK Hynix is poised to keep its position as lead supplier ...

Officials have yet to reach a consensus about how to proceed, according to Bloomberg News. "We can't be expected to comment on pure fiction," a TikTok spokesperson said, responding to the report.

Eli Lilly (LLY) expects that its experimental weight loss pill will get approved as soon as early next year, CEO David Ricks said in an interview with Bloomberg TV at the JPMorgan Healthcare ...

Apple’s (AAPL) new fees for app developers are drawing attention from European Commission watchdogs recently, writes Bloomberg’s Samuel Stolton… Apples new “core technology fee” is 51c ...

13:46 EST Honeywell (HON) plans breakup amid pressure from activist Elliott, Bloomberg reports Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze ...

Facing continued pressure from activist Elliott Investment Management, Honeywell (HON) is set to proceed with a breakup, people familiar with the matter Bloomberg’s David Carnevali. The ...

HP Enterprise (HPE) late last year won a deal worth more than $1B to provide the social network X with servers optimized for artificial intelligence work, Brody Ford of Bloomberg reports ...

15:03 EST HP Enterprise (HPE) jumps 1% to $22.35 after Bloomberg report of X deal Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your ...

At Bank of America (BAC), 10% will be the average increase in store for investment bankers and traders handling stocks, people with direct knowledge told Bloomberg. Meanwhile, Morgan Stanley (MS ...

Apple’s (AAPL) 2025 is likely to be seen as a stepping stone toward more revolutionary products, rather than one of remarkable innovation, Bloomberg’s Mark Gurman says in his “Power On ...

Johnson & Johnson (JNJ) is exploring a bid to acquire Intra-Cellular Therapies (ITCI), a biopharmaceutical company focused on treatments for central nervous system disorders, Bloomberg’s ...